These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38290400)

  • 1. Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing.
    Buenestado-Serrano S; Herranz M; Otero-Sobrino Á; Molero-Salinas A; Rodríguez-Grande C; Sanz-Pérez A; Durán Galván MJ; Catalán P; Alonso R; Muñoz P; Pérez-Lago L; García de Viedma D;
    Int J Med Microbiol; 2024 Mar; 314():151599. PubMed ID: 38290400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Genomic Variants of SARS-CoV-2 Using Nanopore Sequencing.
    Capraru ID; Romanescu M; Anghel FM; Oancea C; Marian C; Sirbu IO; Chis AR; Ciordas PD
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557043
    [No Abstract]   [Full Text] [Related]  

  • 3. A Novel High-Throughput Nanopore-Sequencing-Based Strategy for Rapid and Automated S-Protein Typing of SARS-CoV-2 Variants.
    Wagner GE; Totaro MG; Volland A; Lipp M; Saiger S; Lichtenegger S; Forstner P; von Laer D; Oberdorfer G; Steinmetz I
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis.
    Bull RA; Adikari TN; Ferguson JM; Hammond JM; Stevanovski I; Beukers AG; Naing Z; Yeang M; Verich A; Gamaarachchi H; Kim KW; Luciani F; Stelzer-Braid S; Eden JS; Rawlinson WD; van Hal SJ; Deveson IW
    Nat Commun; 2020 Dec; 11(1):6272. PubMed ID: 33298935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2.
    Carbo EC; Mourik K; Boers SA; Munnink BO; Nieuwenhuijse D; Jonges M; Welkers MRA; Matamoros S; van Harinxma Thoe Slooten J; Kraakman MEM; Karelioti E; van der Meer D; Veldkamp KE; Kroes ACM; Sidorov I; de Vries JJC
    Eur J Clin Microbiol Infect Dis; 2023 Jun; 42(6):701-713. PubMed ID: 37017810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanopore sequencing of SARS-CoV-2: Comparison of short and long PCR-tiling amplicon protocols.
    Brejová B; Boršová K; Hodorová V; Čabanová V; Gafurov A; Fričová D; Neboháčová M; Vinař T; Klempa B; Nosek J
    PLoS One; 2021; 16(10):e0259277. PubMed ID: 34714886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.
    Chan WS; Au CH; Lam HY; Wang CLN; Ho DN; Lam YM; Chu DKW; Poon LLM; Chan TL; Zee JS; Ma ESK; Tang BSF
    Virol J; 2020 Nov; 17(1):183. PubMed ID: 33225958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Nanopore and Synthesis-Based Next-Generation Sequencing Platforms for SARS-CoV-2 Variant Monitoring in Wastewater.
    Garcia-Pedemonte D; Carcereny A; Gregori J; Quer J; Garcia-Cehic D; Guerrero L; Ceretó-Massagué A; Abid I; Bosch A; Costafreda MI; Pintó RM; Guix S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis.
    Hall MB; Rabodoarivelo MS; Koch A; Dippenaar A; George S; Grobbelaar M; Warren R; Walker TM; Cox H; Gagneux S; Crook D; Peto T; Rakotosamimanana N; Grandjean Lapierre S; Iqbal Z
    Lancet Microbe; 2023 Feb; 4(2):e84-e92. PubMed ID: 36549315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of two-pool multiplex long-amplicon nanopore sequencing of SARS-CoV-2.
    Liu H; Li J; Lin Y; Bo X; Song H; Li K; Li P; Ni M
    J Med Virol; 2022 Jan; 94(1):327-334. PubMed ID: 34524690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution and real-time wastewater viral surveillance by Nanopore sequencing.
    Xu X; Deng Y; Ding J; Tang Q; Lin Y; Zheng X; Zhang T
    Water Res; 2024 Jun; 256():121623. PubMed ID: 38657304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting SARS-CoV-2 Omicron B.1.1.529 Variant in Wastewater Samples by Using Nanopore Sequencing.
    Rasmussen LD; Richter SR; Midgley SE; Franck KT
    Emerg Infect Dis; 2022 Jun; 28(6):1296-1298. PubMed ID: 35362410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and clinical utility of local rapid Nanopore influenza A virus whole genome sequencing for integrated outbreak management, genotypic resistance detection and timely surveillance.
    Williams TGS; Snell LB; Alder C; Charalampous T; Alcolea-Medina A; Sehmi JK; Al-Yaakoubi N; Humayun G; Miah S; Lackenby A; Zambon M; Batra R; Douthwaite S; Edgeworth JD; Nebbia G
    Microb Genom; 2023 Aug; 9(8):. PubMed ID: 37590039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of an amplicon-sequencing nanopore approach to identify variants in tuberculosis drug-resistance-associated genes.
    Mariner-Llicer C; Goig GA; Zaragoza-Infante L; Torres-Puente M; Villamayor L; Navarro D; Borras R; Chiner-Oms Á; Comas I
    Microb Genom; 2021 Dec; 7(12):. PubMed ID: 34919513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing.
    Yan Y; Wu K; Chen J; Liu H; Huang Y; Zhang Y; Xiong J; Quan W; Wu X; Liang Y; He K; Jia Z; Wang D; Liu D; Wei H; Chen J
    Virol Sin; 2021 Oct; 36(5):901-912. PubMed ID: 33851337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Nano COVID-19": Nanopore sequencing of spike gene to identify SARS-CoV-2 variants of concern.
    Nimsamer P; Sawaswong V; Klomkliew P; Kaewsapsak P; Puenpa J; Poovorawan Y; Payungporn S
    Exp Biol Med (Maywood); 2023 Oct; 248(20):1841-1849. PubMed ID: 37702217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Occurrences of a 168-Nucleotide Deletion in SARS-CoV-2 ORF8, Unnoticed by Standard Amplicon Sequencing and Variant Calling Pipelines.
    Brandt D; Simunovic M; Busche T; Haak M; Belmann P; Jünemann S; Schulz T; Klages LJ; Vinke S; Beckstette M; Pohl E; Scherer C; Sczyrba A; Kalinowski J
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid genomic characterization of SARS-CoV-2 viruses from clinical specimens using nanopore sequencing.
    Li J; Wang H; Mao L; Yu H; Yu X; Sun Z; Qian X; Cheng S; Chen S; Chen J; Pan J; Shi J; Wang X
    Sci Rep; 2020 Oct; 10(1):17492. PubMed ID: 33060796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portable RT-PCR and MinION Nanopore Sequencing as a Proof-of-Concept SARS-CoV-2 Biosurveillance in Wastewater.
    Pavlyuk OM; Engler J; Strapple C; Stamps BW; Dietrich MT
    MSMR; 2023 May; 30(5):9-14. PubMed ID: 37535262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.